Call Options

26 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$41.33 - $74.26 $1.11 Million - $2 Million
-26,900 Reduced 42.7%
36,100 $1.53 Million
Q1 2024

May 15, 2024

BUY
$56.27 - $73.77 $950,963 - $1.25 Million
16,900 Added 36.66%
63,000 $4.35 Million
Q4 2023

Feb 14, 2024

BUY
$59.06 - $75.72 $2.72 Million - $3.49 Million
46,100 New
46,100 $3.41 Million
Q2 2023

Aug 23, 2023

BUY
$62.68 - $95.05 $2.78 Million - $4.22 Million
44,400 Added 125.78%
79,700 $7.48 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $1.02 Million - $1.54 Million
-21,700 Reduced 38.07%
35,300 $2.34 Million
Q4 2022

Feb 14, 2023

BUY
$30.35 - $53.15 $221,555 - $387,995
7,300 Added 14.69%
57,000 $2.82 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $1.59 Million - $2.45 Million
49,700 New
49,700 $1.65 Million
Q2 2022

Aug 15, 2022

SELL
$35.61 - $76.23 $1.47 Million - $3.16 Million
-41,400 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$57.56 - $82.54 $2.76 Million - $3.96 Million
-48,000 Reduced 53.69%
41,400 $2.95 Million
Q4 2021

Feb 14, 2022

BUY
$72.5 - $100.68 $1.2 Million - $1.66 Million
16,500 Added 22.63%
89,400 $6.96 Million
Q3 2021

Nov 12, 2021

BUY
$90.24 - $124.05 $1.99 Million - $2.74 Million
22,100 Added 43.5%
72,900 $6.68 Million
Q2 2021

Aug 06, 2021

SELL
$93.66 - $139.27 $1.29 Million - $1.92 Million
-13,800 Reduced 21.36%
50,800 $6.51 Million
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $1.15 Million - $1.53 Million
-9,900 Reduced 13.29%
64,600 $7.99 Million
Q4 2020

Feb 12, 2021

BUY
$99.61 - $142.12 $677,348 - $966,416
6,800 Added 10.04%
74,500 $10.1 Million
Q3 2020

Nov 13, 2020

BUY
$72.92 - $102.01 $627,112 - $877,286
8,600 Added 14.55%
67,700 $6.91 Million
Q2 2020

Aug 13, 2020

BUY
$55.75 - $92.75 $239,725 - $398,825
4,300 Added 7.85%
59,100 $5.08 Million
Q1 2020

May 11, 2020

SELL
$37.9 - $104.44 $1.57 Million - $4.32 Million
-41,400 Reduced 43.04%
54,800 $3.2 Million
Q4 2019

Feb 12, 2020

BUY
$77.66 - $99.74 $1.41 Million - $1.81 Million
18,100 Added 23.18%
96,200 $8.84 Million
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $1.05 Million - $1.42 Million
11,600 Added 17.44%
78,100 $7.19 Million
Q2 2019

Aug 20, 2019

BUY
$89.51 - $118.04 $1.65 Million - $2.17 Million
18,400 Added 38.25%
66,500 $7.85 Million
Q1 2019

May 15, 2019

SELL
$61.98 - $96.5 $1.54 Million - $2.39 Million
-24,800 Reduced 34.02%
48,100 $4.17 Million
Q4 2018

Feb 14, 2019

BUY
$56.04 - $82.66 $930,264 - $1.37 Million
16,600 Added 29.48%
72,900 $4.46 Million
Q3 2018

Nov 14, 2018

BUY
$48.29 - $80.6 $550,506 - $918,839
11,400 Added 25.39%
56,300 $4.44 Million
Q1 2018

May 15, 2018

SELL
$39.82 - $57.53 $1.08 Million - $1.56 Million
-27,100 Reduced 37.64%
44,900 $1.81 Million
Q4 2017

Feb 14, 2018

BUY
$46.49 - $60.51 $790,330 - $1.03 Million
17,000 Added 30.91%
72,000 $3.78 Million
Q3 2017

Nov 15, 2017

BUY
$37.05 - $47.12 $2.04 Million - $2.59 Million
55,000
55,000 $2.59 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.